OSAKA UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1931-05-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.osaka-u.ac.jp
Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients
Phase 1
Completed
- Conditions
- Gastric CancerEsophageal CancerLung CancerRenal CancerOral Cancer
- Interventions
- Biological: MogamulizumabBiological: Nivolumab
- First Posted Date
- 2016-10-27
- Last Posted Date
- 2020-03-06
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 16
- Registration Number
- NCT02946671
- Locations
- 🇯🇵
Osaka University, Suita, Osaka, Japan
Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)
- First Posted Date
- 2015-10-16
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 50
- Registration Number
- NCT02577159
- Locations
- 🇯🇵
Sousei Hospital, Kadoma, Osaka, Japan
🇯🇵Osaka University Hospital, Suita, Osaka, Japan
🇯🇵Osaka Central Hospital, Osaka city, Osaka, Japan
Safety Study of CNT-01 in Patients With Idiopathic TGCV
Phase 1
Completed
- Conditions
- Idiopathic Triglyceride Deposit Cardiomyovasculopathy
- Interventions
- Drug: CNT-01 500 mg capsule
- First Posted Date
- 2015-07-20
- Last Posted Date
- 2016-09-28
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 5
- Registration Number
- NCT02502578
- Locations
- 🇯🇵
Cardiovascular Medicine, Osaka University Hospital, Suita, Osaka, Japan
Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
Phase 4
- Conditions
- HyperphosphatemiaRenal Insufficiency, ChronicBone Diseases, Metabolic
- Interventions
- First Posted Date
- 2014-09-11
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 60
- Registration Number
- NCT02237534
- Locations
- 🇯🇵
Osaka University Hospital, Suita, Osaka, Japan
Relationship Between CETP Deficiency and Atherosclerosis in Patients With Hyperalphalipoproteinemia
- Conditions
- HyperalphalipoproteinemiaHyper-LDL-cholesterolemiaHigh Level of Remnant CholesterolLow CETP ActivityCETP Deficiency
- First Posted Date
- 2013-08-05
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 1500
- Registration Number
- NCT01916512
- Locations
- 🇯🇵
Osaka University Graduate School of Medicine, Suita, Osaka, Japan
Stress Management Therapy for Meniere's Disease
Not Applicable
- Conditions
- Meniere's DiseaseStress
- Interventions
- Behavioral: Lifestyle
- First Posted Date
- 2010-04-06
- Last Posted Date
- 2010-04-06
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 200
- Registration Number
- NCT01099046
- Locations
- 🇯🇵
Department of Otolaryngology, Osaka University, School of Medicine, Suita-city, Osaka, Japan
Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy
Phase 1
Completed
- Conditions
- Neovascular MaculopathyAge Related Macular Degeneration
- Interventions
- Biological: VEGFR1 and VEGFR2
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2012-10-16
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 17
- Registration Number
- NCT00791570
- Locations
- 🇯🇵
Ophthalmology, Osaka University Medical School, Suita, Osaka, Japan
Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)
- First Posted Date
- 2008-10-21
- Last Posted Date
- 2015-10-15
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 24
- Registration Number
- NCT00776347
- Locations
- 🇯🇵
Osaka University Hospital, Suita,, Osaka, Japan
Vasopressin and V2 Receptor in Meniere's Disease
Not Applicable
Completed
- Conditions
- Meniere Disease
- Interventions
- Genetic: vasopressin, V2 receptor and cyclic AMP
- First Posted Date
- 2008-01-23
- Last Posted Date
- 2016-03-29
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 135
- Registration Number
- NCT00599560
- Locations
- 🇯🇵
Department of Otolaryngology, Osaka University, School of Medicine, Suita-city, Osaka, Japan
The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease
Not Applicable
Terminated
- Conditions
- Alzheimer DiseaseHypercholesterolemia
- Interventions
- Drug: cholesterol-lowering medicine other than statin(e.g.,Ezetimibe,Colestimide)
- First Posted Date
- 2007-10-23
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 38
- Registration Number
- NCT00548145
- Locations
- 🇯🇵
Osaka University Hospital, Suita, Osaka, Japan
© Copyright 2025. All Rights Reserved by MedPath